CryoPort Ships Research Materials for Emory University

LAKE FOREST, CA -- (MARKET WIRE) -- 12/05/08 -- CryoPort, Inc. (OTCBB: CYRX) today announced it has started a program to ship research materials from the United States to international destinations for the Emory University School of Medicine.

The first phase involved shipping the CryoPort Express(TM) System from the Emory facility in Atlanta to Canada. The program is expected to expand to locations in Asia in early 2009.

Peter Berry, CEO of CryoPort, commented, "Successfully shipping high value biomaterials for major institutions in the research community such as Emory reinforces the diverse applications of the CryoPort Express business model and provides further confirmation of the risk mitigation element of the system when compared to dry ice. Eliminating the need to source and pack the dry ice was also a key factor in the decision by Emory to utilize our service."

To be added to the CryoPort Investor email list, please email with CYRX in the subject line.

About CryoPort, Inc.

CryoPort ( develops leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.


This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Stuart Fine
Carpe DM, Inc.